GTG 4.00% 12.0¢ genetic technologies limited

No wonder the SP is were it is!

  1. 3,068 Posts.
    lightbulb Created with Sketch. 46

    No wonder GTG's SP is where it is!

    GTG are just not disclosing to the market - marketing information, are they..
    What a wasted opportunity IMO.

    Looky here, what I stumbled across doing my research..


    MedLab's ASX market ann today, Where's GTGs?

    ASX Announcement
    Biotech Investor Conference – Emerging Biotech Conquering Global Markets
    SYDNEY, August 17, 2022
    Medlab Clinical Ltd (ASX:MDC) and Genetic Technologies Ltd (ASX:GTG) are pleased to co-present at the “Biotech
    Investor Conference”, held at FB Rice: Patent and Trademark Attorneys in Melbourne 5.00pm on Wednesday 17th August 2022.


    The event is proudly sponsored by FB Rice.

    About the Event:
    Australian biotechnology companies are increasingly offering technology that show promise via the clinical and nonclinical trial path.
    This event provides a great opportunity for biotech’s to showcase progression and plans to investors and shareholders.
    The conference is designed to allow investors to become more knowledgeable in the role of Biotech work happening in
    Australia, and the potential to change global ecosystems by looking at biotech from its core and getting a better
    understanding.
    A copy of Medlab’s presentation on the day can be found attached.
    - ENDS -
    Authorisation & Additional information
    This announcement was authorised by the Board of Directors of Medlab Clinical Limited.
    About Genetic Technologies:
    Genetics Technologies Ltd is an established Australian-based molecular diagnostics company, specialising in the
    development of integrated genetic risk testing.
    Through its revolutionary proprietary technology, GeneType predicts an individual’s risk of developing chronic disease
    and enables physicians to proactively manage patient health. For more information, please visit www.genetype.com
    About Medlab Clinical:
    Medlab Clinical Ltd is an Australian biotechnology company, developing therapeutics using its proprietary delivery
    platform NanoCelle®.
    Its most advanced program is in cancer pain management with lead drug candidate NanaBis™, a medical cannabis
    product for cancer-related bone pain. For more information, please visit www.medlab.co
    Medlab – better medicines, better patient care.

    .
 
watchlist Created with Sketch. Add GTG (ASX) to my watchlist
(20min delay)
Last
12.0¢
Change
-0.005(4.00%)
Mkt cap ! $15.86M
Open High Low Value Volume
12.0¢ 12.5¢ 12.0¢ $773 6.437K

Buyers (Bids)

No. Vol. Price($)
6 26900 12.0¢
 

Sellers (Offers)

Price($) Vol. No.
12.5¢ 5805 1
View Market Depth
Last trade - 14.19pm 17/05/2024 (20 minute delay) ?
GTG (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.